UNSPSC 51372030: Morphine dinicotinate hydrochloride

This classification denotes an opiate with the molecular formula C29H25N3O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7A91YL2XT2, chemically known as morphinan-3,6.alpha.-diol, 7,8-didehydro-4,5.alpha.-epoxy-17-methyl-, dinicotinate (ester), hydrochloride, but more generally known as morphine dinicotinate hydrochloride, which bears US NIH Compound Identifier 166031.

European Medicines Agency schedules morphine dinicotinate hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03332MIG. Most nations, for tariff purposes, schedule morphine dinicotinate hydrochloride under HS 29391100. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)OC(=O)C6CCCNC6)OC(=O)C7CCCNC7.CL.

UNSPSC 51372030 Morphine dinicotinate hydrochloride is a Commodity code that in state and local practice encompasses pharmaceutical procurement across a broader category than the specific active ingredient alone—state and local buyers use this code to solicit generic pharmaceuticals, over-the-counter products, naloxone, and drug management systems through cooperative purchasing arrangements and direct supply agreements. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across multiple jurisdictions and government facilities. The work involves establishing supply contracts with manufacturers or authorized wholesalers for recurring delivery of pharmaceutical inventory to community health facilities, emergency response programs, and state agency locations, with pricing structured around competitive bidding, administrative fee arrangements, and compliance with FDA manufacturing standards and drug supply chain security requirements.

Recent activity spans Florida, Texas, and the upper Midwest through multistate cooperatives. Seminole County, Florida issued IFB 60459723LAS (response deadline Jul 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the procurement required E-Verify compliance, fixed-fee pricing, and potential FEMA funding. The Texas Health and Human Services Commission posted RFI HHS0017013 (Apr 3, 2026 response) to gather vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 (Mar 26, 2026 response) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with evaluation weighted heavily on price competitiveness (75 percent), cGMP and DSCSA compliance required, and contract effective July 1, 2026.